SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 84 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,477,000 | +0.5% | 8,173,937 | -0.9% | 1.28% | -19.8% |
| Q1 2016 | $4,455,000 | -39.8% | 8,250,000 | 0.0% | 1.60% | -48.5% |
| Q4 2015 | $7,404,000 | +181.2% | 8,250,000 | +153.8% | 3.11% | +198.5% |
| Q3 2015 | $2,633,000 | -65.6% | 3,250,000 | +27.9% | 1.04% | -65.1% |
| Q2 2015 | $7,650,000 | +200.6% | 2,541,459 | +144.7% | 2.98% | +166.2% |
| Q1 2015 | $2,545,000 | -10.9% | 1,038,652 | +159.7% | 1.12% | -8.7% |
| Q3 2014 | $2,856,000 | +123.3% | 400,000 | +106.6% | 1.23% | +83.7% |
| Q1 2014 | $1,279,000 | – | 193,567 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lamond Capital Partners LLC | 1,320,000 | $9,425,000 | 10.46% |
| RA Capital Management | 4,869,261 | $34,767,000 | 4.11% |
| GREAT POINT PARTNERS LLC | 400,000 | $2,856,000 | 1.23% |
| Healthcare Value Capital, LLC | 100,000 | $714,000 | 0.69% |
| DSC Advisors, L.P. | 175,000 | $1,250,000 | 0.63% |
| Quantitative Systematic Strategies LLC | 107,416 | $803,000 | 0.47% |
| Visium Asset Management, LP | 4,093,890 | $29,230,000 | 0.43% |
| Rhenman & Partners Asset Management AB | 201,171 | $1,436,000 | 0.42% |
| EAM Investors, LLC | 277,807 | $1,984,000 | 0.40% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 354,861 | $2,534,000 | 0.39% |